tiprankstipranks
Trending News
More News >
Rhythm Pharmaceuticals (RYTM)
NASDAQ:RYTM
US Market

Rhythm Pharmaceuticals (RYTM) Income Statement

Compare
598 Followers

Rhythm Pharmaceuticals Income Statement

Last quarter (Q4 2025), Rhythm Pharmaceuticals's total revenue was $57.25M, an increase of 36.87% from the same quarter last year. In Q4, Rhythm Pharmaceuticals's net income was $-47.51M. See Rhythm Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 189.76M$ 130.13M$ 77.43M$ 23.64M$ 3.15M
Gross Profit
$ 170.26M$ 116.76M$ 68.13M$ 21.50M$ 2.56M
Operating Expenses
$ 362.28M$ 382.26M$ 252.48M$ 200.66M$ 172.61M
Depreciation and Amortization
$ 1.34M$ 1.56M$ 1.76M$ 1.67M$ 1.16M
EBITDA
$ -174.12M$ -238.09M$ -168.46M$ -174.25M$ -68.45M
Operating Income
$ -192.02M$ -265.50M$ -184.36M$ -179.16M$ -170.06M
Other Income/Expenses
$ -4.03M$ 5.25M$ 243.00K$ -1.96M$ 100.45M
Pretax Income
$ -196.04M$ -260.26M$ -184.11M$ -181.12M$ -69.61M
Net Income
$ -196.54M$ -260.60M$ -184.68M$ -181.12M$ -69.61M
Per Share Metrics
Basic EPS
$ -3.11$ -4.34$ -3.20$ -3.51$ -1.37
Diluted EPS
$ -3.11$ -4.34$ -3.20$ -3.51$ -1.37
Weighted Average Shares Outstanding
64.98M 60.99M 57.67M 52.12M 49.60M
Weighted Average Shares Outstanding (Diluted)
64.98M 60.99M 57.67M 52.12M 49.60M
Currency in USD

Rhythm Pharmaceuticals Earnings and Revenue History